Antiretroviral Pregnancy Registry Lights Way For Pregnancy Postmarketing Studies

The 30+ year-old program, which monitors prenatal exposure to 164 drugs, should be the template for other efforts, US FDA officials say, because disease-based pregnancy registries ‘have a better track record.’